CCDC102A抗体;CCDC102A Antibody—艾普蒂

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P13030(CCDC102A Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

The CCDC102A antibody targets the protein encoded by the coiled-coil domain-containing 102A (*CCDC102A*) gene, which is implicated in various cellular processes. CCDC102A, a member of the coiled-coil domain-containing protein family, is structurally characterized by conserved α-helical domains that mediate protein-protein interactions. While its precise biological function remains under investigation, emerging studies suggest roles in ciliogenesis, cell cycle regulation, and intracellular signaling. Dysregulation of CCDC102A has been tentatively linked to ciliopathies, reproductive disorders, and certain cancers, highlighting its potential as a biomarker or therapeutic target.

The CCDC102A antibody is a crucial tool for detecting and analyzing the expression, localization, and interactions of the CCDC102A protein in research settings. It is commonly employed in techniques like Western blotting, immunofluorescence, and immunohistochemistry to study tissue-specific expression patterns or subcellular distribution. Validated antibodies typically undergo specificity checks using knockout controls or siRNA-mediated knockdown to ensure minimal cross-reactivity. Researchers utilize this antibody to explore CCDC102A's involvement in cellular pathways, its response to physiological or pathological stimuli, and its association with disease mechanisms. Continued characterization of CCDC102A and its antibody reagents may advance understanding of its functional roles and therapeutic relevance.